There is abundant evidence to show that elevated levels or abnormal activation of STAT3 contribute to cancer cell proliferation, including breast cancer [41], prostate cancer [42], colon cancer [43], and leukemia [44]. Here, STAT3 is linked to prostate carcinoma.